Titre : Phosphotransferases phosphomutases

Phosphotransferases phosphomutases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Text Messaging
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Phosphotransferases phosphomutases : Questions médicales les plus fréquentes", "headline": "Phosphotransferases phosphomutases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Phosphotransferases phosphomutases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-08", "dateModified": "2025-03-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Phosphotransferases phosphomutases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Intramolecular transferases", "url": "https://questionsmedicales.fr/mesh/D019751", "about": { "@type": "MedicalCondition", "name": "Intramolecular transferases", "code": { "@type": "MedicalCode", "code": "D019751", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.399.520" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Bisphosphoglycerate mutase", "alternateName": "Bisphosphoglycerate Mutase", "url": "https://questionsmedicales.fr/mesh/D001731", "about": { "@type": "MedicalCondition", "name": "Bisphosphoglycerate mutase", "code": { "@type": "MedicalCode", "code": "D001731", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.399.520.750.250" } } }, { "@type": "MedicalWebPage", "name": "Phosphoglucomutase", "alternateName": "Phosphoglucomutase", "url": "https://questionsmedicales.fr/mesh/D010733", "about": { "@type": "MedicalCondition", "name": "Phosphoglucomutase", "code": { "@type": "MedicalCode", "code": "D010733", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.399.520.750.625" } } }, { "@type": "MedicalWebPage", "name": "Phosphoglyceromutase", "alternateName": "Phosphoglycerate Mutase", "url": "https://questionsmedicales.fr/mesh/D010736", "about": { "@type": "MedicalCondition", "name": "Phosphoglyceromutase", "code": { "@type": "MedicalCode", "code": "D010736", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.399.520.750.700" } } } ], "about": { "@type": "MedicalCondition", "name": "Phosphotransferases phosphomutases", "alternateName": "Phosphotransferases (Phosphomutases)", "code": { "@type": "MedicalCode", "code": "D017875", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Stewart Shuman", "url": "https://questionsmedicales.fr/author/Stewart%20Shuman", "affiliation": { "@type": "Organization", "name": "Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA shumans@mskcc.org." } }, { "@type": "Person", "name": "Jean-Marc Jeckelmann", "url": "https://questionsmedicales.fr/author/Jean-Marc%20Jeckelmann", "affiliation": { "@type": "Organization", "name": "Institute of Biochemistry and Molecular Medicine, Medical Faculty, University of Bern, Bern, Switzerland." } }, { "@type": "Person", "name": "Balraj Doray", "url": "https://questionsmedicales.fr/author/Balraj%20Doray", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA." } }, { "@type": "Person", "name": "Benjamin C Jennings", "url": "https://questionsmedicales.fr/author/Benjamin%20C%20Jennings", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA." } }, { "@type": "Person", "name": "Wang-Sik Lee", "url": "https://questionsmedicales.fr/author/Wang-Sik%20Lee", "affiliation": { "@type": "Organization", "name": "Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Perception of nurses on the use of mobile phone text messaging for the management of diabetes mellitus in rural Ghana.", "datePublished": "2023-01-07", "url": "https://questionsmedicales.fr/article/36611225", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/nop2.1596" } }, { "@type": "ScholarlyArticle", "name": "Effect of Text Messaging and Behavioral Interventions on COVID-19 Vaccination Uptake: A Randomized Clinical Trial.", "datePublished": "2022-06-01", "url": "https://questionsmedicales.fr/article/35696165", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2022.16649" } }, { "@type": "ScholarlyArticle", "name": "Tailored text messages to improve breastfeeding practices in Yangon, Myanmar: the M528 individually randomized controlled trial.", "datePublished": "2023-01-10", "url": "https://questionsmedicales.fr/article/36811470", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajcnut.2023.01.003" } }, { "@type": "ScholarlyArticle", "name": "SmilesUp text message intervention for early childhood dental caries prevention: A protocol for a randomised controlled trial.", "datePublished": "2024-09-30", "url": "https://questionsmedicales.fr/article/39348422", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0310561" } }, { "@type": "ScholarlyArticle", "name": "Text messages to improve child diets: Formative research findings and protocol of a randomised controlled trial in Nepal.", "datePublished": "2023-03-02", "url": "https://questionsmedicales.fr/article/36864635", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/mcn.13490" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Isomerases", "item": "https://questionsmedicales.fr/mesh/D007535" }, { "@type": "ListItem", "position": 5, "name": "Intramolecular transferases", "item": "https://questionsmedicales.fr/mesh/D019751" }, { "@type": "ListItem", "position": 6, "name": "Phosphotransferases phosphomutases", "item": "https://questionsmedicales.fr/mesh/D017875" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Phosphotransferases phosphomutases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Phosphotransferases phosphomutases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Phosphotransferases phosphomutases", "description": "Comment diagnostiquer une déficience en phosphomutases ?\nQuels tests sont utilisés pour évaluer l'activité des phosphomutases ?\nQuels symptômes peuvent indiquer un problème avec les phosphomutases ?\nLes tests génétiques sont-ils utiles pour le diagnostic ?\nQuelle imagerie peut aider à diagnostiquer des troubles liés aux phosphomutases ?", "url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Text+Messaging&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Phosphotransferases phosphomutases", "description": "Quels sont les symptômes d'une déficience en phosphomutases ?\nLes douleurs musculaires sont-elles liées aux phosphomutases ?\nPeut-on observer des anomalies métaboliques ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des signes cliniques spécifiques à surveiller ?", "url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Text+Messaging&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Phosphotransferases phosphomutases", "description": "Peut-on prévenir les troubles liés aux phosphomutases ?\nY a-t-il des conseils diététiques pour prévenir les symptômes ?\nLes tests de dépistage sont-ils recommandés ?\nComment le suivi médical aide-t-il à la prévention ?\nLes vaccinations ont-elles un rôle dans la prévention ?", "url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Text+Messaging&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Phosphotransferases phosphomutases", "description": "Quels traitements sont disponibles pour les troubles liés aux phosphomutases ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nY a-t-il des traitements expérimentaux en cours ?\nComment la nutrition influence-t-elle le traitement ?", "url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Text+Messaging&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Phosphotransferases phosphomutases", "description": "Quelles complications peuvent survenir avec une déficience en phosphomutases ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des risques de complications à long terme ?\nLes complications peuvent-elles être prévenues ?", "url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Text+Messaging&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Phosphotransferases phosphomutases", "description": "Quels sont les facteurs de risque pour les troubles des phosphomutases ?\nL'environnement joue-t-il un rôle dans ces troubles ?\nLes habitudes alimentaires influencent-elles le risque ?\nY a-t-il des groupes à risque spécifique ?\nLe stress peut-il affecter le risque de troubles ?", "url": "https://questionsmedicales.fr/mesh/D017875?mesh_terms=Text+Messaging&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en phosphomutases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses biochimiques sont utilisés pour diagnostiquer." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité des phosphomutases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests d'activité enzymatique in vitro mesurent la fonction des phosphomutases." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec les phosphomutases ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles métaboliques, fatigue et douleurs musculaires peuvent survenir." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent identifier des mutations spécifiques liées aux phosphomutases." } }, { "@type": "Question", "name": "Quelle imagerie peut aider à diagnostiquer des troubles liés aux phosphomutases ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie par résonance magnétique (IRM) peut être utilisée pour évaluer les tissus." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en phosphomutases ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, faiblesse musculaire et troubles de la croissance." } }, { "@type": "Question", "name": "Les douleurs musculaires sont-elles liées aux phosphomutases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs musculaires peuvent survenir en raison de troubles métaboliques." } }, { "@type": "Question", "name": "Peut-on observer des anomalies métaboliques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans le métabolisme des glucides et des lipides peuvent être présentes." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent se manifester différemment selon l'âge et le développement." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques spécifiques à surveiller ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'hypoglycémie et des troubles neurologiques peuvent être observés." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés aux phosphomutases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un diagnostic précoce peut aider à gérer les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des conseils diététiques pour prévenir les symptômes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et riche en nutriments peut aider à prévenir certains symptômes." } }, { "@type": "Question", "name": "Les tests de dépistage sont-ils recommandés ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de dépistage peuvent être recommandés pour les familles à risque." } }, { "@type": "Question", "name": "Comment le suivi médical aide-t-il à la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier permet de surveiller les symptômes et d'ajuster le traitement." } }, { "@type": "Question", "name": "Les vaccinations ont-elles un rôle dans la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne préviennent pas directement les troubles enzymatiques, mais aident à la santé générale." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles liés aux phosphomutases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des suppléments enzymatiques et des modifications diététiques." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche pour traiter certaines déficiences enzymatiques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à gérer les symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments peuvent être prescrits pour gérer les symptômes associés." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux en cours ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, plusieurs études cliniques explorent de nouveaux traitements pour ces troubles." } }, { "@type": "Question", "name": "Comment la nutrition influence-t-elle le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Une nutrition adéquate peut améliorer la gestion des symptômes et le métabolisme." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une déficience en phosphomutases ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles métaboliques graves et des problèmes neurologiques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Y a-t-il des risques de complications à long terme ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des risques de complications à long terme existent, nécessitant un suivi médical." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par un traitement précoce et un suivi régulier." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles des phosphomutases ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux et certaines mutations génétiques augmentent le risque." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle dans ces troubles ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux peuvent influencer l'expression des gènes liés aux phosphomutases." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise alimentation peut exacerber les symptômes et augmenter le risque de complications." } }, { "@type": "Question", "name": "Y a-t-il des groupes à risque spécifique ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes avec des antécédents familiaux de troubles métaboliques sont à risque accru." } }, { "@type": "Question", "name": "Le stress peut-il affecter le risque de troubles ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut aggraver les symptômes et influencer le métabolisme." } } ] } ] }

Sources (3428 au total)

Perception of nurses on the use of mobile phone text messaging for the management of diabetes mellitus in rural Ghana.

This study aims to explore the perception of nurses on the use of mobile phone SMS for managing diabetes in rural Ghana.... Exploratory Descriptive Qualitative Design.... Purposive sampling was used to recruit (13) participants relative to data saturation after ethical clearance (REDACTED); using a semi-structured interview guide. All interviews were transcribed verbat... Participants believe SMS was useful in facilitating interaction between nurses, clients, family and statistically significant others; improving medication adherence and supporting blood glucose monito... Thirteen nurses actively participated in the study....

Effect of Text Messaging and Behavioral Interventions on COVID-19 Vaccination Uptake: A Randomized Clinical Trial.

COVID-19 vaccine uptake among urban populations remains low.... To evaluate whether text messaging with outbound or inbound scheduling and behaviorally informed content might increase COVID-19 vaccine uptake.... This randomized clinical trial with a factorial design was conducted from April 29 to July 6, 2021, in an urban academic health system. The trial comprised 16 045 patients at least 18 years of age in ... Eligible patients were randomly assigned in a 1:20:20 ratio to (1) outbound telephone call only by call center, (2) text message and outbound telephone call by call center to those who respond, or (3)... The primary outcome was the proportion of patients who completed the first dose of the COVID-19 vaccine within 1 month, according to the electronic health record. Secondary outcomes were the completio... Among the 16 045 patients included, the mean (SD) age was 36.9 (11.1) years; 9418 (58.7%) were women; 12 869 (80.2%) had commercial insurance, and 2283 (14.2%) were insured by Medicaid; 8345 (52.0%) w... There was no detectable increase in vaccination uptake among patients receiving text messaging compared with telephone calls only or behaviorally informed message content.... ClinicalTrials.gov Identifier: NCT04834726....

Tailored text messages to improve breastfeeding practices in Yangon, Myanmar: the M528 individually randomized controlled trial.

Text messages are a feasible delivery channel for breastfeeding promotion, but only a few articles have examined their effectiveness.... To evaluate the impact of mobile phone text messages on breastfeeding practices.... We implemented a 2-arm, parallel, individually randomized controlled trial with 353 pregnant participants at the Central Women's Hospital, Yangon. The intervention group (n = 179) received breastfeedi... Exclusive breastfeeding prevalence was significantly higher in the intervention than in the control group for the 6 follow-up visits combined (RR: 1.48; 95%CI: 1.35, 1.63; P < 0.001) and at each month... Regular, targeted text messages delivered to urban pregnant women and mothers via mobile phones significantly improve breastfeeding practices and reduce infant morbidity during the first 6 mo of life.... Australian New Zealand Clinical Trials Registry ACTRN12615000063516; https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=367704....

SmilesUp text message intervention for early childhood dental caries prevention: A protocol for a randomised controlled trial.

Despite improvements in health outcomes for children, early childhood dental caries (ECC) remains a chronic lifestyle-mediated disease that affects an estimated 600 million children worldwide. Parenta... A randomised controlled trial with a 1:1 parallel design will be conducted among 150 parents with children diagnosed with ECC and accessing public dental care in NSW, Australia. Patients will be strat... Ethics approval has been obtained from the Western Sydney Local Health District Human Research Ethics Committee 2022/ETH01920. Study results will be disseminated via peer-reviewed publications and pre... Trial registration number: This clinical trial has been prospectively registered on the ANZCTR from the 27th of March 2023. Registration number: ACTRN12623000325606....

The effectiveness of a motivational text-messaging program for smoking cessation after coronary angioplasty: a quasi-experimental study.

Smoking is an important risk factor of coronary artery stenosis after angioplasty. Therefore, this investigation aimed to determine the effectiveness of a motivational text-messaging program for smoki... Success in quitting cigarette smoking was significantly higher in the intervention group (n = 29, 61.7%) compared to the control group (n = 2, 4.3%) (p < 0.001). Moreover, after the intervention, the ...

Effect of a Text Message-Based Support Program on Outcomes of Patients After Flexor Tendon Injury Repair.

Although the effectiveness of using text messages in home-based rehabilitation programs has been investigated, its ability to engage patients in home rehabilitation exercises and, as a result, improve... In this 2-arm parallel randomized controlled trial, 40 patients were randomly assigned to either the intervention group (usual care plus the support program) or the control group (usual care only). In... The study was completed by 90% (36 of 40) of the patients who were enrolled. There were statistically significant differences between the 2 groups with respect to Quick Disabilities of the Arm, Should... The text message-based program was associated with improved outcomes over the first 12 weeks after flexor tendon repair.... Therapeutic II....

Assessment of a Text Message-Based Smoking Cessation Intervention for Adult Smokers in China: A Randomized Clinical Trial.

Successful smoking cessation strategies are an important part of reducing tobacco use. However, providing universal smoking cessation support can be a challenge for most countries because it requires ... To assess the efficacy of a behavior change theory-based smoking cessation intervention using personalized text messages.... This study was a 2-arm double-blind randomized clinical trial conducted in 5 cities in China. Daily or weekly smokers 18 years or older were eligible for inclusion if they owned a mobile phone and use... Intervention group participants received a personalized text message-based smoking cessation intervention that was based on the transtheoretical model and protection motivation theory and developed by... The primary outcome was the biochemically verified 6-month sustained abstinence rate, defined as the self-report of no smoking of any cigarettes after the designated quit date, which was validated bio... A total of 722 participants (mean [SD] age, 41.5 [12.7] years; 716 men [99.2%]; all of Chinese ethnicity) were randomly assigned to the intervention group (360 participants) or the control group (362 ... In this study, the behavior change theory-based smoking cessation intervention using personalized text messages was more effective than an intervention using nonpersonalized text messages. The interve... Chinese Clinical Trial Registry Identifier: ChiCTR2100041942....

Design of a Temporally Augmented Text Messaging Bot to Improve Adolescents' Physical Activity and Engagement: Proof-of-Concept Study.

Digital interventions hold promise for improving physical activity in adolescents. However, a lack of empirical decision points (eg, timing of intervention prompts) is an evidence gap in the optimizat... The study examined the feasibility and acceptability, as well as the technical and functional reliability, of and participant engagement with a digital intervention that aligned its decision points to... Ten adolescents completed a 7-day baseline monitoring period and Temporally Augmented Goal Setting (TAGS), a 20-day digital physical activity intervention that included a midday self-monitoring messag... The TAGS intervention was mostly feasible, acceptable, and technically and functionally reliable. Adolescents showed adequate levels of engagement. Preintervention to intervention changes in MVPA were... TAGS shows promise for future trials with additional refinements given its feasibility, acceptability, technical and functional reliability, participants' rates of engagement, and the relative MVPA im...

Effectiveness of Text Messaging in Encouraging Smoking Cessation among Non-Communicable Disease Patients: A Randomized Controlled Trial.

To assess the impact of a text-messaging intervention on smoking cessation among patients with non-communicable diseases.... A total of 200 participants were randomly assigned to either a text-messaging intervention group or a control group. The 7-day point prevalence of smoking cessation and exhaled carbon monoxide (CO) le... The 7-day point prevalence of smoking cessation increased by 16.16% (95% CI: 10.98, 21.33) at the 6-week follow-up and by 15.46% (95% CI: 10.68, 21.33) at the 18-week follow-up. In the intervention gr... The text-messaging intervention proved effective in increasing the prevalence of smoking cessation and reducing carbon monoxide levels among non-communicable disease patients....